Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide

PHASE2CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

February 29, 2000

Study Completion Date

December 31, 2001

Conditions
HIV InfectionsChlamydia TrachomatisNeisseria GonorrhoeaeTrichomonas VaginitisSyphilisHerpes Simplex
Interventions
DRUG

Carraguard (PC-515)

Trial Locations (1)

57001

Chiang Rai Health Club, Chiang Rai

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Centers for Disease Control and Prevention

FED

collaborator

Nat'l Cntr. for HIV, STD, & TB Prevention Atlanta: Division of STD Prevention,Div. of HIV/AIDS Prevention-Surveillance & Epidemiology

UNKNOWN

collaborator

National Center for Infectious Diseases

OTHER_GOV

collaborator

Ministry of Health, Thailand

OTHER_GOV

collaborator

Collaboration (TUC)

UNKNOWN

collaborator

Chiang Rai Public Health Office

OTHER_GOV

collaborator

Chiang Rai District Health Office

OTHER_GOV

collaborator

Chiang Rai Municipal Health Office

OTHER_GOV

collaborator

Chiang Rai Hospital

OTHER

lead

Population Council

OTHER

NCT00213031 - Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide | Biotech Hunter | Biotech Hunter